Search clinical trials for: High-Dose Quadrivalent Influenza Vaccine

Total 2807 results

University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Seroprotection

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients

Influenza

United States
Rebecca Cox
Haukeland University Hospital; European Commission

Completed

Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults (PANFLUVAC)

Healthy | Influenza

Norway
Makerere University

Unknown

Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial (PREST)

Preventing Stroke in Sickle Cell Anaemia

Uganda
Rockefeller University

Terminated

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

Metabolic Syndrome | Immune Deficiency

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
Vanderbilt University
Centers for Disease Control and Prevention; Marshfield Clinic Research Foundation

Completed

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

Aging
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
Federico Martinón Torres

Recruiting

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

Influenza

Spain
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Bone Marrow and Peripheral Blood Immune Responses Study

Influenza

United States
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Stony Brook University
University of North Carolina, Chapel Hill

Completed

Flu Vaccine Response in Patients on Biologic Therapies

Inflammatory Bowel Diseases | Immune Complex Diseases | Rheumatologic Disorder

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - T Cells

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Antibody

Influenza

United States
Sungkyunkwan University
Government-wide R&D Fund project for infectious disease research (GFID)

Unknown

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Pregnancy Related | Influenza Virus Vaccine Adverse Reaction
University of Wisconsin, Madison

Completed

Immunological Consequences of Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Fundación Pública Andaluza Progreso y Salud
Spanish Network for Research in Infectious Diseases

Completed

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination (TraNsgripe)

Infection in Solid Organ Transplant Recipients

Spain
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Influenza Disease

Italy
Tel-Aviv Sourasky Medical Center

Unknown

Influenza Vaccination in Patients With Scleroderma

Influenza Vaccine in Scleroderma

Israel
Novartis
Novartis Vaccines; Chiron s.r.l. Beijing Representative Office

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Coronavirus Disease 2019

China
Jiangsu Province Centers for Disease Control and...

Active, not recruiting

Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine

COVID-19

China
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Italy, Belgium, France, Lithuania
Sanofi

Completed

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Influenza | Orthomyxoviridae Infections

United States
Oswaldo Cruz Foundation
Ministry of Health, Brazil

Completed

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults (VIP-H1N1)

HIV Infection

Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Influenza

United States
Ology Bioservices

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza

Austria, Finland
Sanofi Pasteur, a Sanofi Company

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Czech Republic, Lithuania, Belgium
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza
CureVac

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies

Belgium, Germany
Beijing Northland Biotech. Co., Ltd.

Completed

Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction

Acute Myocardial Infarction

China
MedImmune LLC

Completed

A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.

Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)

United States, Puerto Rico
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Safety Issues

Indonesia
Mitsubishi Tanabe Pharma Corporation

Completed

Exploratory Clinical Study of MT-2301

Haemophilus Influenza Type b

Japan
Buhai Wang
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Cervix Cancer | Cervical Neoplasms

China
Marker Therapeutics, Inc.

Completed

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

Breast Cancer

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI); The Emmes Company, LLC

Completed

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Infection | Precancerous Condition

United States
University of Milan

Unknown

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

HIV | HPV

Italy
Medstar Health Research Institute
Merck Sharp & Dohme LLC

Completed

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

Cervical Cancer | Warts | Hpv

United States
The University of Hong Kong

Completed

Intradermal Influenza Vaccine in the Young

Influenza Viral Infections

China
Beijing Northland Biotech. Co., Ltd.

Completed

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Acute Myocardial Infarction

China
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions

Influenza, Human

Germany
Johns Hopkins Bloomberg School of Public Health

Completed

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Cholera | Vibrio Cholerae Infection

Zambia
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Avian Influenza | Immunisation

United States
Washington University School of Medicine

Unknown

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

Immunity, Cellular

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season

Influenza

United States

Search clinical trials for: High-Dose Quadrivalent Influenza Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations